OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parkinson disease: from pathology to molecular disease mechanisms
David T. Dexter, Peter Jenner
Free Radical Biology and Medicine (2013) Vol. 62, pp. 132-144
Closed Access | Times Cited: 644

Showing 1-25 of 644 citing articles:

The Role of Oxidative Stress in Parkinson's Disease
Vera Dias, Eunsung Junn, M. Maral Mouradian
Journal of Parkinson s Disease (2013) Vol. 3, Iss. 4, pp. 461-491
Open Access | Times Cited: 1483

The SH-SY5Y cell line in Parkinson’s disease research: a systematic review
Helena Xicoy, Bé Wieringa, Gerard J.M. Martens
Molecular Neurodegeneration (2017) Vol. 12, Iss. 1
Open Access | Times Cited: 810

Dopamine: Functions, Signaling, and Association with Neurological Diseases
Marianne Klein, Daniella S. Battagello, Ariel R. Cardoso, et al.
Cellular and Molecular Neurobiology (2018) Vol. 39, Iss. 1, pp. 31-59
Closed Access | Times Cited: 802

Effects of Ionizing Radiation on Biological Molecules—Mechanisms of Damage and Emerging Methods of Detection
Julie A. Reisz, Nidhi Bansal, Jiang Qian, et al.
Antioxidants and Redox Signaling (2014) Vol. 21, Iss. 2, pp. 260-292
Open Access | Times Cited: 710

Parkinson’s Disease in Women and Men: What’s the Difference?
Silvia Cerri, Liudmila Mus, Fabio Blandini
Journal of Parkinson s Disease (2019) Vol. 9, Iss. 3, pp. 501-515
Open Access | Times Cited: 586

Parkinson's Disease and Parkinsonism
Michael T. Hayes
The American Journal of Medicine (2019) Vol. 132, Iss. 7, pp. 802-807
Closed Access | Times Cited: 558

Sex differences in Parkinson’s disease
Glenda E. Gillies, Ilse S. Pienaar, Shiv Vohra, et al.
Frontiers in Neuroendocrinology (2014) Vol. 35, Iss. 3, pp. 370-384
Open Access | Times Cited: 423

Role of Cardiolipin in Mitochondrial Function and Dynamics in Health and Disease: Molecular and Pharmacological Aspects
Giuseppe Paradies, Valeria Paradies, Francesca Ruggiero, et al.
Cells (2019) Vol. 8, Iss. 7, pp. 728-728
Open Access | Times Cited: 363

Hydroxytyrosol: Bioavailability, toxicity, and clinical applications
María Robles-Almazán, Mario Pulido-Morán, Jorge Moreno‐Fernández, et al.
Food Research International (2017) Vol. 105, pp. 654-667
Closed Access | Times Cited: 260

Dopamine, Oxidative Stress and Protein–Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases
Enrico Monzani, Stefania Nicolis, Simone Dell’Acqua, et al.
Angewandte Chemie International Edition (2018) Vol. 58, Iss. 20, pp. 6512-6527
Closed Access | Times Cited: 217

Depression in neurodegenerative diseases: Common mechanisms and current treatment options
Ciarán Galts, Luis E.B. Bettio, David C. Jewett, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 102, pp. 56-84
Closed Access | Times Cited: 213

The Role of Lipids in Parkinson’s Disease
Helena Xicoy, Bé Wieringa, Gerard J.M. Martens
Cells (2019) Vol. 8, Iss. 1, pp. 27-27
Open Access | Times Cited: 201

Mitochondrial dysfunction in the development and progression of neurodegenerative diseases
Joseph Johnson, Elizabeth Mercado‐Ayón, Yesica Mercado-Ayon, et al.
Archives of Biochemistry and Biophysics (2020) Vol. 702, pp. 108698-108698
Closed Access | Times Cited: 194

The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction
Yuri Zilberter, Misha Zilberter
Journal of Neuroscience Research (2017) Vol. 95, Iss. 11, pp. 2217-2235
Open Access | Times Cited: 193

Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice
Jinbo Cheng, Yajin Liao, Yuan Dong, et al.
Autophagy (2020) Vol. 16, Iss. 12, pp. 2193-2205
Open Access | Times Cited: 181

The sinister face of heme oxygenase-1 in brain aging and disease
Hyman M. Schipper, Wei Song, Ayda Tavitian, et al.
Progress in Neurobiology (2018) Vol. 172, pp. 40-70
Closed Access | Times Cited: 173

Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of parkin-mediated mitophagy in in-vitro and in-vivo models of Parkinson disease
Sahabuddin Ahmed, Mohit Kwatra, Samir Ranjan Panda, et al.
Brain Behavior and Immunity (2020) Vol. 91, pp. 142-158
Closed Access | Times Cited: 165

Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities
Vicente Javier Clemente‐Suárez, Laura Redondo-Flórez, Ana Isabel Beltrán-Velasco, et al.
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2488-2488
Open Access | Times Cited: 66

The cellular model for Alzheimer's disease research: PC12 cells
Danni Xie, Ting Deng, Zhenwei Zhai, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 15
Open Access | Times Cited: 47

Resveratrol Partially Prevents Rotenone-Induced Neurotoxicity in Dopaminergic SH-SY5Y Cells through Induction of Heme Oxygenase-1 Dependent Autophagy
Tsu‐Kung Lin, Shang‐Der Chen, Yao‐Chung Chuang, et al.
International Journal of Molecular Sciences (2014) Vol. 15, Iss. 1, pp. 1625-1646
Open Access | Times Cited: 154

Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress
Mohammed Akbar, Musthafa Mohamed Essa, Ghazi Daradkeh, et al.
Brain Research (2016) Vol. 1637, pp. 34-55
Open Access | Times Cited: 154

Paths from Pesticides to Parkinson's
Freya Kamel
Science (2013) Vol. 341, Iss. 6147, pp. 722-723
Open Access | Times Cited: 132

Cardiac abnormalities in Parkinson’s disease and Parkinsonism
Fulvio A. Scorza, Ana C. Fiorini, Carla A. Scorza, et al.
Journal of Clinical Neuroscience (2018) Vol. 53, pp. 1-5
Closed Access | Times Cited: 132

Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson’s Disease
Kuo‐Hsuan Chang, Mei‐Ling Cheng, Hsiang-Yu Tang, et al.
Molecular Neurobiology (2018) Vol. 55, Iss. 8, pp. 6319-6328
Closed Access | Times Cited: 130

Mesenchymal Stem Cells-derived Exosomes: A New Possible Therapeutic Strategy for Parkinson’s Disease?
Helena Vilaça-Faria, António J. Salgado, Fábio G. Teixeira
Cells (2019) Vol. 8, Iss. 2, pp. 118-118
Open Access | Times Cited: 126

Page 1 - Next Page

Scroll to top